The Precision Hypertension Care Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 280 participants.

Also called NCT02774460

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 280 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02774460
Other papers using this trial's data
  • Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial JAMA, 2023-04-11 DOI, PubMed 37039792, PMC10091169 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02774460. Randomized; quadruple masking; primary purpose treatment. Start 2017-02-20 (actual); primary completion 2021-06-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Precision Hypertension Care Study
Acronym
PHYSIC
Condition
Hypertension
Intervention (Drug)
Zestril®
Intervention (Drug)
Atacand®
Intervention (Drug)
Norvasc®
Intervention (Drug)
Hydrochlorthiazide®
Intervention (Drug)
Treatment X
Intervention (Drug)
Treatment Y
Intervention (Drug)
Placebo
Lead sponsor
Uppsala University (class: other)

Record details

Record id
cardio:ct-nct02774460
Content hash
1aa969fc38cb161d9e88fd22ff74990a5329c18e4e9d4118c69b58fddfbe9348